School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou University City, Waihuan East Road 132, Guangzhou 510006, People's Republic of China.
J Med Chem. 2011 Aug 25;54(16):5671-9. doi: 10.1021/jm200062u. Epub 2011 Jul 29.
G-Quadruplex is a special DNA secondary structure and present in many important regulatory regions in human genome, such as the telomeric end and the promoters of some oncogenes. Specially, different forms of G-quadruplexes exist in telomeric DNA and c-myc promoter and play important roles in the pathway of cell proliferation and senescence. The effects of G-quadruplex ligands for either telomeric or c-myc G-quadruplex in vitro have been widely studied, but the specificity of these effects in vivo is still unknown. In the present research, various experiments were carried out to study the effect of G-quadruplex ligand SYUIQ-05 on tumor cell lines and the mechanism of this effect. Our results showed that it preferred to bind with G-quadruplex in c-myc and had rather insignificant effect on G-quadruplex in telomere. Therefore, it is possible that this compound had its antitumor activity for cancer cells mainly through its interaction with c-myc quadruplex.
G-四链体是一种特殊的 DNA 二级结构,存在于人类基因组的许多重要调控区域,如端粒末端和一些癌基因的启动子。特别是,不同形式的 G-四链体存在于端粒 DNA 和 c-myc 启动子中,在细胞增殖和衰老的途径中发挥重要作用。G-四链体配体在体外对端粒或 c-myc G-四链体的作用已经得到了广泛的研究,但这些作用在体内的特异性仍然未知。在本研究中,进行了各种实验来研究 G-四链体配体 SYUIQ-05 对肿瘤细胞系的影响及其作用机制。我们的结果表明,它优先与 c-myc 中的 G-四链体结合,对端粒中的 G-四链体几乎没有影响。因此,这种化合物可能主要通过与 c-myc 四链体的相互作用发挥其抗肿瘤活性。